Fumaric Acid

Fumaric Acid

SCHEMBL8540329

CN1C[C@@H]2CCC[C@H](c3ccc(Cl)c(Cl)c3)[C@@H]2C1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 9/20 0.45
SLC6A2 known ✓ P23975 5/20 0.45
KCNH2 known ✓ Q12809 1/20 0.41
SLC6A3 Q01959 10/20 0.45
HRH2 P25021 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL8546918 0.84 GAA (0.38) SLC6A3SLC6A4SLC6A2
Fumaric Acid SCHEMBL8545846 0.83 MEN1 (0.41) SLC6A3SLC6A4SLC6A2HRH2
Fumaric Acid SCHEMBL8544579 0.82 ALDH1A1 (0.37) SLC6A3SLC6A4SLC6A2
Fumaric Acid SCHEMBL8546233 0.82 HRH3 (0.36) SLC6A3SLC6A4SLC6A2
Fumaric Acid SCHEMBL8541348 0.82 HRH3 (0.36) SLC6A3SLC6A4SLC6A2
Fumaric Acid SCHEMBL8543943 0.81 HRH2 (0.46) SLC6A3SLC6A4SLC6A2HRH2
Fumaric Acid SCHEMBL8547447 0.79 SLC6A3 (0.43) SLC6A3SLC6A4SLC6A2KCNH2
Fumaric Acid SCHEMBL8542175 0.76 KDM4E (0.42)
Fumaric Acid SCHEMBL8540901 0.76 KDM4E (0.41)
Oxalic Acid SCHEMBL8540602 0.74 CCR2 (0.41) SLC6A3SLC6A4SLC6A2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0690842-B1 4-ARYLISOINDOLE ANALGESICS ORTHO PHARMA CORP (US) 1998-12-16 EP disclosed
US-5508424-A REDUCED SIDE EFFECTS ORTHO PHARMACEUTICAL CORPORATION (US) 1996-04-16 US disclosed
WO-1994022823-A1 4-ARYLISOINDOLE ANALGESICS ORTHO PHARMACEUTICAL CORPORATION (US) 1994-10-13 WO disclosed